However, because c-Abl is known to increase p53 activation via inactivation of Mdm2/Hdm2, an E3 ubiquitin-ligase for p53 [30, 46], we propose that the pathogenic action of c-Abl in α-synucleinopathy may involve p53. This evidence concerns the gene TP53 and synucleinopathy.